Literature DB >> 10381013

North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group.

M Eccles1, N Freemantle, J Mason.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381013     DOI: 10.1093/fampra/16.2.103

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


× No keyword cloud information.
  16 in total

1.  Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project.

Authors:  M Eccles; J Mason; N Freemantle
Journal:  Qual Health Care       Date:  2000-06

2.  Fatal toxicity associated with antidepressant use in primary care.

Authors:  J Mason; N Freemantle; M Eccles
Journal:  Br J Gen Pract       Date:  2000-05       Impact factor: 5.386

3.  When should clinical guidelines be updated?

Authors:  P Shekelle; M P Eccles; J M Grimshaw; S H Woolf
Journal:  BMJ       Date:  2001-07-21

4.  A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.

Authors:  Nick Freemantle; Irwin Nazareth; Martin Eccles; John Wood; Andrew Haines
Journal:  Br J Gen Pract       Date:  2002-04       Impact factor: 5.386

5.  Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.

Authors:  N Freemantle; J Mason
Journal:  BMJ       Date:  1999-05-29

6.  The dilemma of new drugs. Are costs rising faster than effectiveness?

Authors:  J Mason; N Freemantle
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 7.  Venlafaxine extended-release: a review of its use in the management of major depression.

Authors:  K Wellington; C M Perry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  Problem solving treatment and group psychoeducation for depression: multicentre randomised controlled trial. Outcomes of Depression International Network (ODIN) Group.

Authors:  C Dowrick; G Dunn; J L Ayuso-Mateos; O S Dalgard; H Page; V Lehtinen; P Casey; C Wilkinson; J L Vazquez-Barquero; G Wilkinson
Journal:  BMJ       Date:  2000-12-09

Review 9.  Escitalopram: a pharmacoeconomic review of its use in depression.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Clinical oral examinations may not be predictive of dysplasia or oral squamous cell carcinoma.

Authors:  Jennifer L Cleveland; Valerie A Robison
Journal:  J Evid Based Dent Pract       Date:  2013-10-11       Impact factor: 5.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.